Gene Therapy for Eye Diseases

Over the last decade it has become increasingly clear that eye disorders are amongst the most amenable targets for gene therapy. This issue surveys ocular gene transfer using AAV and lentiviral vectors which are the most effective vector platforms for the eye and also surveys gene therapy approaches for the treatment of a range of retinal disorders, including inherited retinopathies, glaucoma and retinal and choroidal neovascularisation.

Guest Editor Robin R Ali, University College London, United Kingdom